Source:http://linkedlifedata.com/resource/pubmed/id/17505990
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2007-5-16
|
pubmed:abstractText |
Prompt and long-standing acid control following once-daily administration of antisecretory drugs is desirable. The objective of this study was to determine whether co-administration of a well-characterized H2-receptor antagonist, famotidine, can be combined with the proton-pump inhibitor omeprazole.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0036-5521
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
42
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
689-94
|
pubmed:meshHeading |
pubmed-meshheading:17505990-Adult,
pubmed-meshheading:17505990-Cross-Over Studies,
pubmed-meshheading:17505990-Drug Administration Schedule,
pubmed-meshheading:17505990-Drug Therapy, Combination,
pubmed-meshheading:17505990-Famotidine,
pubmed-meshheading:17505990-Humans,
pubmed-meshheading:17505990-Omeprazole
|
pubmed:year |
2007
|
pubmed:articleTitle |
Can famotidine and omeprazole be combined on a once-daily basis?
|
pubmed:affiliation |
Department of Gastrosurgical Research, Sahlgrenska University Hospital, Gothenburg, Sweden. lars.fandriks@gastro.gu.se
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|